Showing 20 of 64 recruiting trials for “angiocentric-glioma”
Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell Lymphoma
Effect of Electroacupuncture Combined With Paclitaxel Clinical Efficacy of Patients With Recurrence of High-grade Glioma
🏥 The Third Affiliated hospital of Zhejiang Chinese Medical University📍 1 site📅 Started Apr 2024View details ↗
Personalized Rendering of Motor System Functional Plasticity Potential to Improve Glioma Resection and Quality of Life
Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma
RecruitingNCT06362148 ↗
Circulating Tumor DNA in Peripheral T-cell Lymphomas
👨⚕️ Francesco A d'Amore, MD, DMSc, Aarhus University Hospital and Aarhus University📍 1 site📅 Started Mar 2024View details ↗
RecruitingNCT06036381 ↗
Spatial and Temporal Characterization of Gliomas Using Radiomic Analysis
PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
PET and EBV DNA-directed Therapy for Localized Nasal Extranodal NK/T Cell Lymphoma
RecruitingNCT06620055 ↗
Development of an Artificial Intelligence Model for Optimising Therapy in Gliomas Gliomas
👨⚕️ Giuseppe Toffoli, Centro di Riferimento Oncologico di Aviano (CRO) - IRCCS📍 3 sites📅 Started Nov 2023View details ↗
Feasibility of Individualized, Model-guided Optimization of Proton Beam Treatment Planning in Patients With Low Grade Glioma
RecruitingNCT06043232 ↗
MMR/MSI Phenotypes in Prediction of Tumor Vaccine Benefit for Gliomas
RecruitingNCT06138340 ↗
The Effects of Anesthetics on Brain Network Connectivity in Patients With Supratentorial Glioma
RecruitingNCT05386043 ↗
Registering Genomics and Imaging of Tumors (ReGIT)
Evaluation of Diagnostic Performances of 18F-FDOPA PET KInetics
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma
Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG
Clinical Study of XPO1 Inhibitor Selinexor Combined With COPL in Newly Diagnosed Advanced NK/T-cell Lymphoma
RecruitingNCT05259605 ↗
Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →